The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Celldex Therapeutics, Inc(NASDAQ:CLDX) 
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The...
Website: http://www.celldex.com
Founded: 1983
Full Time Employees: 127
Sector: Healthcare
Industry: Biotechnology
Celldex Therapeutics Days Payable Outstanding ttm (DPO)
Celldex Therapeutics Days Receivable Outstanding ttm (DSO)
Celldex Therapeutics Op Cashflow Per Share ttm
Celldex Therapeutics Free Cashflow Per Share ttm
Celldex Therapeutics Cash Per Share ttm
Celldex Therapeutics P/S ratio ttm
Celldex Therapeutics (GAAP) P/E ratio ttm
Celldex Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.